Innate Pharma (IPHA) Payables (2017 - 2026)
Innate Pharma (IPHA) recorded Payables of $13.1 million in the quarter ended Jun 30, 2026, down 3.9% from $13.63 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Payables (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma reported Payables of $16.99 million, down 1.9% from the prior year.
- Annual Payables has declined for seven straight years, with a five-year compound annual growth rate of -12.8% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Payables came in at $17.32 million in the year ended Dec 31, 2024 (-5.9%), $18.41 million in the year ended Dec 31, 2023 (-16.5%), $22.04 million in the year ended Dec 31, 2022 (-32.6%) and $32.69 million in the year ended Dec 31, 2021 (-3.1%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Payables in data going back to the quarter ended Dec 31, 2017.
- On a year-over-year basis, Payables rose in 1 of the last four quarters, with an average decline of 7.1%.
- Peak year-over-year performance for Payables in the last five years was growth of 3.8% in the quarter ended Jun 30, 2023, against a decline of 34.7% in the quarter ended Dec 31, 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Innate Pharma | 142.45 Mn | -64.74 Mn | - | 12.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.87 Mn |
| Dec 31, 2025 | 17.67 Mn |
| Jun 30, 2025 | 14.12 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Dec 31, 2023 | 18.84 Mn |
| Jun 30, 2023 | 20.64 Mn |
| Dec 31, 2022 | 22.29 Mn |
| Jun 30, 2022 | 19.50 Mn |
| Dec 31, 2021 | 32.36 Mn |
| Jun 30, 2021 | 20.26 Mn |
| Dec 31, 2020 | 36.33 Mn |
| Jun 30, 2020 | 29.85 Mn |
| Dec 31, 2019 | 55.46 Mn |
| Dec 31, 2018 | 104.85 Mn |
| Dec 31, 2017 | 29.44 Mn |
API Access
Innate Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();